Inhibitors of GH secretion include SRLs, dopamine agonizts and GHRH antagonists.42,43,111 SRLs bind to the somatostatin receptors that are present in the tumor and suppress the secretion of GH from the pituitary. Here, GH1 is linked to neoplasm.